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Abstract
Background: The Dickkopf (DKK) family comprises a set of proteins that function as regulators of Wnt/b–catenin signaling
and has a crucial role in development. Recent studies have revealed the involvement of this family in tumorigenesis,
however their role in tumorigenesis is still remained unclear.
Methodology/Principal Findings: We found increased expression of DKK2 but decreased expression of DKK1 in Ewing
family tumor (EFT) cells. We showed that EFT-specific EWS/ETS fusion proteins enhance the DKK2 promoter activity, but not
DKK1 promoter activity, via ets binding sites (EBSs) in the 59 upstream region. EWS/ETS-mediated transactivation of the
promoter was suppressed by the deletion and mutation of EBSs located upstream of the DKK2 gene. Interestingly, the
inducible expression of EWS/ETS resulted in the strong induction of DKK2 expression and inhibition of DKK1 expression in
human primary mesenchymal progenitor cells that are thought to be a candidate of cell origin of EFT. In addition, using an
EFT cell line SK-ES1 cells, we also demonstrated that the expression of DKK1 and DKK2 is mutually exclusive, and the ectopic
expression of DKK1, but not DKK2, resulted in the suppression of tumor growth in immuno-deficient mice.
Conclusions/Significance: Our results suggested that DKK2 could not functionally substitute for DKK1 tumor-suppressive
effect in EFT. Given the mutually exclusive expression of DKK1 and DKK2, EWS/ETS regulates the transcription of the DKK
family, and the EWS/ETS-mediated DKK2 up-regulation could affect the tumorigenicity of EFT in an indirect manner.
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Introduction
The Wnt/b–catenin signaling pathway is known to regulate
development, differentiation, and a variety of biological phenom-
ena. Recent findings support notion that the aberration of
canonical Wnt/b–catenin signaling is involved in malignant
transformation [1,2,3]. Mutations in components of the pathway
have been observed in primary human cancers. These mutations
often allow ligand-independent Wnt/b–catenin signaling in tumor
cells. Among the components, the tumor suppressor Adenomatous
polyposis coli (APC) and the scaffold protein Axin are frequently
mutated in colon cancer [4] and hepatocellular carcinoma [5]
respectively. Mutations in b–catenin itself are also found in a
number of cancers. These changes induce the stabilization of b–
catenin in the cytoplasm and an abnormal accumulation of free b–
catenin in the nucleus, resulting in the aberrant activation of Wnt
target genes through T-cell factor family members.
A number of activators and antagonists in the Wnt/b–catenin
signaling pathway have been cloned and investigated. The
Dickkopf (DKK) family is comprised of secreted protein
modulators of Wnt/b–catenin signaling [6,7]. In human, the
family consists of DKK1, DKK2, DKK3/REIC and DKK4, all of
which have two cysteine-rich domains. DKK1 interacts with low-
density lipoprotein receptor (LRP) 5/6, a component of the Wnt
receptor complex, and inhibits canonical Wnt/b–catenin signaling
(Mao et al. 2001). DKK2 is structurally very similar to DKK1 and
also interacts with LRP5/6, but its effect on Wnt/b–catenin
signaling is thought to be rather agonistic [8,9]. DKKs have been
found to be important in multiple developmental processes such as
limb development [10,11,12] and bone formation [13,14].
In addition, it has been recently reported that DKKs play a
crucial role in cell transformation [15]. Hyper-methylation of the
promoter and gene silencing of DKK1 were observed in tumor
cells, including colorectal cancer [16] and malignant melanoma
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suppresses features of transformation in tumor cells [18,19,20],
DKK1 might inhibit tumorigenicity. However, the expression of
DKK1 is elevated in some tumor cells including myeloma cells
[21], hepatoblastoma cells and Wilm’s tumor cells [22]. Therefore,
the molecular function of DKK1 in cancer is controversial and still
not fully elucidated. DKK3/REIC is also proposed as a tumor
suppressor. The overexpression of DKK3/REIC inhibits tumor
growth in prostate cancer [23], melanoma [17] and hepatocellular
carcinoma [24]. The down-regulated expression of DKK3/REIC
in osteosarcoma [25,26], hepatoblastma [26] and prostate cancer
[27] further supports this notion. Although these studies indicate
that the modulation of DKK expression contributes to tumorige-
nicity, the underlying molecular mechanism is not fully under-
stood.
Ewing family tumor (EFT) is a pediatric cancer arising from
bone and soft tissues. In EFT, a specific translocation results in
production of the fusion protein EWS/ETS, where the C-terminal
of EWS, including the RNA-binding domain, is replaced with a
DNA-binding domain of the ets gene family, such as FLI1, ERG,
E1AF, ETV1 and FEV [28]. The consequent fusion proteins have
been proposed to act as an aberrant transcriptional regulator and
believed to play an important role in the initiation and
development of EFT. EWS/FLI1, transactivates the expression
of cyclin D1 [29], cyclin E [30] and TERT [31] through the Sp1,
E2F or ets DNA-binding sites located in each promoter, but
suppresses the expression of p21 [32] and TGFBRII [33,34].
In this paper, we present evidence of enhanced DKK2 but
suppressed expression of DKK1 in EFT cells. The experiments
including those using inducible EWS/ETS expression systems in
human primary bone marrow-derived mesenchymal progenitor
cells (hMPCs) [35] demonstrated that the expression of DKKs is
regulated by the EFT-specific chimeric protein, EWS/ETS. We
further address the role of DKKs in the tumorigenicity of EFT.
Materials and Methods
Animals
All the animals used in this study were treated in accordance
with regulation on Animal Experimentation at National Research
Institute for Child Health and Development.
Plasmid construction
To construct a luciferase reporter vector using the 59upstream
region of the DKK2 gene, the 21955/+49 genomic fragment of the
gene was amplified by PCR from human lymphocyte genomic
DNA and cloned into the EcoRV site of the reporter vector pGL4
(Promega) to generate pGL4-DKK2. Serial deletions of pGL4-
DKK2 were generated by digestion with restriction enzymes and
subsequent self-ligation. The resultant reporter vectors were
designated pGL4-DKK2DKpnI( 21741/+49), pGL4-DKK2DNheI
(21241/+49) and pGL4-DKK2DSacI( 2521/+49). Mutagenesis of
putative ets binding sites (EBS) in the DKK2 59upstream region was
performed using KOD-plus (TOYOBO). The primers used for the
mutagenesis were as follows: for the 21585/21573 genomic
fragment of the DKK2 59upstream region (designated EBS-1): 59-
CTACCTTAAA GAAACCTTAT TCAAAAGATA39 and 59-
AGATTTTTCA CATTTTAGTG TGTGGGGTTT-39; for the
2904/2895 genomic fragment of the DKK2 59upstream region
(designated EBS-2): 59-GCACCTTGCC AAGGAAGACA
GGATCTCAAA-39 and 59-CTTCTAGCCC CAGTGAATTA
CAAGAGAAGC-39. A flag-tag and a Gateway cassette were
amplified from pifw [36] by PCR and the product was inserted into
the EcoRV site of pcDNA
TM3 (Invitrogen) (termed pcDNA3-
flagDEST). Full-length EWS/FLI1 type II, EWS/ERG and EWS/
E1AF cDNAs were amplified from cDNAs prepared from NCR-
EW2 [37], W-ES [38] and NCR-EW3 cells [37], respectively, by
Figure 1. The expression pattern of the DKK family in Ewing’s
family tumor (EFT). A, B, Real-time RT-PCR analysis using pediatric
tumor cell lines for DKK1 (A) and DKK2 (B) expression. EFT: Ewing’s
family tumor, NB: neuroblastoma, BL: Burkitt lymphoma, RMS:
Rhabdomyosarcoma, EC: embryonal carcinoma. Data are normalized
to the mRNA level in SCCH196 (for DKK1) and Ramos (for DKK2) which is
arbitrarily set to 1. Signal intensity was normalized using that of a
control housekeeping gene (human GAPDH gene). Data are relative
values with the SD for triplicate wells.
doi:10.1371/journal.pone.0004634.g001
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PLoS ONE | www.plosone.org 2 February 2009 | Volume 4 | Issue 2 | e4634Figure 2. The effect of EWS/ETS expression on the activity of the DKK2 promoter. A, Schematic representation of the 59upstream region of
the DKK2 gene. The nucleotide numbering represents the distance from the translation start site (+1). KpnI( 21741), NheI( 21241), and SacI( 2521)
sites were used to construct a series of deletion mutants of the DKK2 promoter (see Materials and Methods). Consensus ets binding sites are boxed
(EBS-1, EBS-2 and EBS-3). B, Western blot analysis for EWS/ETS expression. HEK293 cells were transiently transfected with pcDNA3-flagDEST or
pcDNA3-flagEWS/ETS and then analyzed by anti-flag Western blotting. C, The effect of EWS/ETS expression on the activity of the DKK2 promoter.
HEK293 cells were co-transfected with reporter plasmids and the expression vector. Luciferase activity was measured after 48 hours. Data are relative
values with the SD for triplicate wells. Data are normalized to the value for the empty vector (pcDNA3-flagDEST) which is arbitrarily set to 1. The
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TM11
(Invitrogen). The resulting pENTR11-EWS/ETSs were recom-
bined with pcDNA3-flagDEST using the LR recombination
reaction as instructed by the manufacturer (Invitrogen) to construct
the flag-tagged EWS/ETS expression vector pcDNA3-flagEWS/
ETSs. The human DKK1 and DKK2 cDNAs without a stopcodon
were subcloned into pENTR
TM11 and the resulting pENTR11-
DKK1 and pENTR11-DKK2 were recombined with pcDNA-
DEST40 C-terminally V5-His-tagged (Invitrogen) using the LR
recombinationreactionas instructed by the manufacturer, to obtain
pcDNA-DEST40-DKK1 and -DKK2.
Cell cultures
H4-1 (primary hMPCs), UEET-12, UET-13 (hMPCs with an
extended life span through retroviral transduction) [39] and UET-
13 transfectants [35] were cultured in Dulbecco’s modified Eagle’s
medium (DMEM) with 10% Fetal Bovine Serum (FBS) or Tet
System Approved FBS (Takara) at 37uC under a humidified 5%
transfection efficiency was normalized relative to the b–galactosidase activity (See Materials and Methods). D, Schematic representation of a series of
deletion mutants of the DKK2 59 upstream region. KpnI (21741), NheI (21241) and SacI (2521) sites were used to construct a series of deletion
mutants of the DKK2 promoter (see Materials and Methods). E, F, G, The transactivation of deletion mutants of the DKK2 promoter by EWS/ETS
expression. HEK293 cells were co-transfected with reporter plasmids and the expression vector. Data are normalized to the value for the empty vector
(pcDNA3-flagDEST) which is arbitrarily set to 1. Luciferase activity was measured after 48 hours. Data are relative values with the SD for triplicate
wells. The transfection efficiency was normalized relative to the b–galactosidase activity (See Materials and Methods).
doi:10.1371/journal.pone.0004634.g002
Figure 3. Mutational analysis of EBS in the DKK2 promoter. A, The substitutions in EBS-1 and EBS-2. The underlined sequences indicate the
mutated sequences in EBS. B, C, The suppression of EWS/ETS-mediated activation of the DKK2 promoter by the mutations. HEK293 cells were co-
transfected with mutated reporter plasmids and the expression vector. Luciferase activity was measured after 48 hours. Data are relative values with
the SD for triplicate wells. Data are normalized to the value for the empty vector (pcDNA3-flagDEST) that is arbitrarily set to 1. The transfection
efficiency was normalized relative to the b–galactosidase activity (See Materials and Methods).
doi:10.1371/journal.pone.0004634.g003
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SK-ES1, NCR-EW2, NCR-EW3 and W-ES, neuroblastoma (NB)
cell lines NB9, NB69 and GOTO, and Rhabdomyosarcoma
(RMS) cell line NRS-1 were maintained as described previously
[35]. Other NB cell lines NB1, NB19 [40], CHP134 and IMR32
[41], the Burkitt lymphoma (BL) cell lines BJAB, Ramos, Daudi,
P3HR1 and Raji (obtained from Japanese Collection of Research
Bioresources, JCRB, Osaka, Japan) were cultured in RPMI 1640
medium with 10% FBS. Embryonal carcinoma (EC) cell lines
NCR-G2 and NCR-G3 [42] were cultured in a 1:1 mixture of
DMEM and Ham’s F12 medium with 10% FBS.
HEK293 cells were cultured in DMEM with 10% FBS. Stable
transfection of HEK293 cells with pcDNA3-flagDEST or
pcDNA3-flagEWS/FLI1 was performed using Lipofectamine
TM
2000 (Invitrogen) according to the manufacturer’s directions.
Individual resistant clones were selected in the presence of
1000 mg/ml of G418 for a month and designated as HEK-DEST
and HEK-EWS/FLI1 cells.
For the generation of SK-ES1 transfectants with DKK1 and
DKK2, SK-ES1 cells transfected with pcDNA-DEST40-DKK1
and -DKK2, respectively and selected as described above. The
consequent stable transfectants were designated SK-ES1-DKK1
and -DKK2, respectively. As a negative control, SK-ES1 cells
were also transfected with empty vector pcDNA-DEST40 and
designated as SK-ES1-DEST.
Western blot analysis
The Western blot analysis was performed as described [43].
Briefly, cell lysate was prepared, separated on a 10% SDS-PAGE
gel, and transferred onto a PVDF membrane. After blocking with
5% skim milk in PBS containing 0.01% Tween-20 (Sigma)
(PBST), the membrane was incubated with appropriate primary
and secondary antibodies. As the primary antibody, anti-flag M2
(Sigma), anti-V5 (Invitrogen) or anti-Actin (Sigma) was used.
HRP-conjugated anti-rabbit or anti-mouse IgG antibody (Dako-
Cytomation) was used as the secondary antibody. Blots were
Figure 4. Direct binding of EWS/FLI1 to EBS of the DKK2 promoter. A, Immunoprecipitation (IP) and Western blot analysis of HEK293 cells
stably transfected with pcDNA3-flagDEST (HEK-DEST) or pcDNA3-flagEWS/FLI1 (HEK-EWS/FLI1). Cells were lysed and Immunoprecipitated by anti-flag
antibodies. The IP products were analyzed by Westen blot analysis. B, Real-time RT-PCR analysis using HEK293 transfectants for DKK2 expression.
Data are normalized to the mRNA level in HEK-DEST cells which is arbitrarily set to 1. Signal intensity was normalized using that of a control
housekeeping gene (human GAPDH gene). Data are relative values with the SD for triplicate wells. DEST: HEK-DEST cells; FLI1: HEK-EWS/FLI1. C, D,
Binding of EWS/FLI1 to EBS of the DKK2 promoter in vivo. The ChIP analysis was done as described under Materials and Methods. For the ChIP analysis
using HEK293 transfectants, soluble chromatin was immunoprecipitated with anti-flag antibodies or normal mouse immunoglobulin (IgG) and
analyzed by PCR. For the ChIP analysis using SK-ES1 cells, soluble chromatin was immunoprecipitated with anti-FLI1 antibodies or normal rabbit
immunoglobulin (IgG) and analyzed by PCR. The upper figure indicates a schematic representation of the site of the DKK2 promoter detected in the
ChIP analysis. Arrows indicate the position of the specific primer used for ChIP.
doi:10.1371/journal.pone.0004634.g004
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PLoS ONE | www.plosone.org 5 February 2009 | Volume 4 | Issue 2 | e4634Figure 5. The change in expression pattern of the DKK family with EWS/ETS’s induction in UET-13 cells. A, The expression pattern of
DKKs in hMPCs and EFT cells. DKK1 and DKK2 mRNAs in the H4-1, UEET-12, UET-13 and EFT cell lines were detected by RT-PCR. As an internal control,
a human GAPDH gene was used. B, The expression of DKK2 protein in hMPCs and EFT cells. For the detection of secreted DKK2, cells were cultured
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(GE Healthcare Bio-Science Corp) and exposed to X-ray film
(Kodak) for 5–30 minutes. Secreted DKK2 was detected using
anti-DKK2 antibody (Biovision). For the detection of secreted
DKKs-V5 proteins, 20 ml of each cell culture supernatant in SK-
ES1 transfectants was collected and added to BD TALON Metal
Affinity Resin (Clontech). After incubation overnight, the
supernatant was removed. The resin-protein complex was purified
and analyzed by Western blotting as described above.
Immunoprecipitation (IP)
IP was performed as described previously [44]. Whole cell
extracts were incubated with anti-flag M2 antibody (Sigma) and
the protein-antibody complex was bound to protein G-Dynal
beads (Invitrogen). The bound complexes were washed and
collected by centrifugation and separated by SDS-PAGE.
Reporter assay
HEK293 cells were transiently transfected with a mixture of
100 ng of pGL4 or the pGL4-DKK2 reporter vector series and
300 ng of pcDNA3-flagDEST or pcDNA3-flagEWS/ETS using
Lipofectamine
TM 2000 (Invitrogen). The cells were also transfect-
ed with 25 ng of pcDNA/GW-40/LacZ (Invitrogen) for the
standardization of transfection efficiency. The luciferase activity
and b-gal activity were measured 48 h after the transfection as
described before (Mon et al., 2003).
RT-PCR analysis
RT-PCR analysis was performed as described [35]. Total RNA
was extracted from cells using a RNeasy kit (QIAGEN) and reverse
transcribed using a First-Strand cDNA Synthesis Kit (GE Healthcare
Bio-Science Corp). The primers used for the detection of DKK1 and
DKK2 were as follows: DKK1 primers, 59-CGCTAGTCCC
ACCCGCGGAG GGGACGCAGG -39 and 59-CCTTCTTTCA
GGACAGGTTT ACAGATCTTG -39; DKK2 primers, 59-
GAAGCGCTGC CACCGAGATG GCATGTGCTG -39 and 59-
GATGATCGTA GGCAGGGGTC TCCTTCATGC -39). For the
detection of DKK-V5 fusion transcripts, the following V5-specific
primer was used: V5 (reverse): 59-ACGCGTAGAATCGAGACC-
GAGAGAGGGTT-39. The human GAPDH gene was detected as
an internal control with the following primers: GAPDH (forward):59-
CCACCCATGG CAAATTCCAT GGCA-39, GAPDH (reverse):
59-TCTAGACGGC AGGTCAGGT CCACC-39. PCR products
were electrophoresed with a 1% agarose gel and stained by ethidium
bromide.
Real-time RT-PCR analysis
Real-time RT-PCR was performed using SYBRH Green PCR
Master Mix, TaqManH Universal PCR Master Mix and
TaqManH Gene Expression Assays, Inventoried assay on an ABI
PRISMH 7900HT Sequence Detection System (Applied Biosys-
tems) according to the manufacturer’s instructions. The human
GAPDH gene was used as an internal control for normalization.
Subcutaneous tumorigenicity assay
Immuno-deficient mice (CB17-SCID 8 weeks old, Clea Japan,
Inc) were maintained under pathogen-free conditions. SK-ES1
transfectants were suspended in 100 ml of PBS and injected s.c. into
mice. Cells were injected at a density of 1610
7 cells per body. Mice
were monitored weekly and tumor diameter was measured with
precision calipers. Mice were sacrificed after 28 days of monitoring.
Chromatin immunoprecipitation (ChIP) assay
For preparing the antibody- protein G-Dynal beads (Invitrogen)
complex, protein G-Dynal beads were washed with 0.5% BSA in
PBS, and anti-flag antibody, anti-FLI1 antibody (Santa cruz) or
mouse IgG was added. The beads mixtures were incubated and
rotated overnight at 4uC. HEK-EWS/FLI1 cells or SK-ES1 cells
were cross-linked by 1% formaldehyde for 10 minutes at room
temperature. The medium was aspirated and the cells were lysed
using cell lysis buffer A [50 mM HEPES pH 7.5, 140 mM NaCl,
1 mM EDTA, 10% glycerol, 0.5% NP-40, 0.25% Triton X-100,
and Complete protease inhibitor cocktail (Roche)]. The cells were
pelleted and resuspended in cell lysis buffer B [10 mM Tris-HCl
pH 8.0, 200 mM NaCl, 1 mM EDTA, 0.5 mM EGTA, and
Complete protease inhibitor cocktail]. Nuclei were then pelleted
and lysed with cell lysis buffer C [10 mM Tris-Hcl pH 8.0,
100 mM NaCl, 1 mM EDTA, 0.5 mM EGTA, 0.1% deoxycho-
late, 0.5% N-lauroylsarcosine, Complete protease inhibitor
cocktail] on ice. The nuclear lysates were sonicated and then
precleared with salmon sperm DNA/ protein G-Dynal beads for
3 hours. The cleared supernatant was incubated with anti-flag
antibody, anti-FLI1 antibody or mouse IgG- protein G-Dynal
beads complex. Sixteen hours after the incubation, the immune
complexes were collected with centrifugation and washed 7 times
using RIPA buffer [50 mM HEPES pH 7.5, 500 mM LiCl, 1 mM
EDTA, 1% NP-40, 0.7% N-lauroylsarcosine, and Complete
protease inhibitor cocktail]. The DNA-protein cross-linking was
reversed by heating at 65uC. The chromatin was purified and
analyzed by PCR using specific primers (EBS-2: 59-GCAG-
GAAGCC AAGGAAGACA-39 and 59-GCGAATAGGA
AATCCCAGAT AGG-39). PCR products were electrophoresed
with a 2% agarose gel and stained by SYBRH Green I (Takara).
Results
Increased DKK2 and suppressed DKK1 expression in EFT
cells
To identify the specific genes related to EFT cells, DNA
microarray-based global expression profiling was done using EFT
cell lines and other tumors found in children. By comparing the
expression patterns, genes were identified as typically up-regulated
in EFT cells and other cells (data not shown). Among these genes,
we particularly focused on DKK2 (up-regulated) and DKK1
(down-regulated) because they are members of the DKK family
and structurally well related, but revealed opposite expression
patterns in EFT cells. Similar results were obtained from the
microarray assay using EFT and NB tissue samples in the Gene
for 48 hours and then the culture medium was analyzed by Western blotting. C, D, E, F, Relative level of DKK1 (C, D) and DKK2 (E, F) in UET-13
transfectants in the absence or presence of tetracycline. UET-13 transfectants were treated with or without 3 mg/ml of tetracycline for the indicated
periods. Real-time RT-PCR was performed to investigate the expression pattern of the DKK family. Signal intensity was normalized using that of a
control housekeeping gene (human GAPDH gene). Data are relative values with the SD for triplicate wells and normalized to the mRNA level at
0 hour which is arbitrarily set to 1.
doi:10.1371/journal.pone.0004634.g005
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PLoS ONE | www.plosone.org 7 February 2009 | Volume 4 | Issue 2 | e4634Figure 6. Mutually exclusive expression of DKK1 and DKK2 in SK-ES1 cells. A, B, Validation of DKK-V5 expression in SK-ES1 cells. The
expression of DKK1-V5 and DKK2-V5 in SK-ES1 transfectants was observed by RT-PCR (A) and Western blot analysis (B). DEST#1, #2: SK-ES1-DEST#1,
#2, DKK1#1, #2: SK-ES1-DKK1#1, #2, DKK2#1, #2: SK-ES1-DKK2#1, #2. As an internal control, human GAPDH (for RT-PCR) and b–Actin (for
Western blot) were used, respectively. C, Secretion of DKKs-V5 into cell culture supernatants. Secreted DKKs-V5 proteins were absorbed by TALON
Metal Affinity Resin (Clontech) and analyzed by Western blotting, D, E, Relative level of DKK1 and DKK2 in SK-ES1 transfectants in SK-ES1-DKK1 (D)
and SK-ES1-DKK2 (E). Signal intensity was normalized using that of a control housekeeping gene (human GAPDH gene). Data are relative values with
the SD for triplicate wells and normalized to the mRNA level at DEST#1 which is arbitrarily set to 1.
doi:10.1371/journal.pone.0004634.g006
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GSE1825) (data not shown).
We first confirmed the expression pattern of DKK genes
obtained with the microarray assay by conducting a Real-time
RT-PCR analysis. The increased expression of DKK2 was
confirmed in EFT cells (Fig. 1A). DKK2 expression was especially
increased in NCR-EW3 cells that express EWS/E1AF. In contrast,
the expression of DKK1 was suppressed in most EFT cells (Fig. 1B).
Direct regulation of DKK2, but not DKK1, promoter
activity by EWS/ETS proteins
Previous reports revealed that EWS/ETS proteins enhance the
promoter activity of several genes via the ets DNA-binding sites on
the promoters [45]. A sequence analysis and TF search (http://
www.cbrc.jp/ research/db/TFSEARCH.html) revealed the 59
upstream region (21955 to +49) of the DKK2 gene to have two
putative EBSs, here designated EBS-1 (21585 to 21573) and
EBS-2 (2904 to 2895). Although, the TF search did not recognize
it, we also found a putative EBS (GGAA/T) element, designated
as EBS-3 (2140 to 2131). Thus, we next isolated the 59 upstream
region of the DKK2 gene and cloned it into the reporter plasmid
pGL4 (DKK2 full-Luc) (Fig. 2A) to test the effects of EWS/ETS
expression on DKK2 promoter activity with transient transfection
reporter assays in HEK293 cells. As shown in Fig. 2B and C, co-
transfection of EWS/ETS with pGL4-DKK2 resulted in an
enhancement of reporter activity ,10-fold compared with co-
transfection with empty expression vector. To map the site in the
DKK2 59 upstream region required for activation by EWS/ETS
expression, reporter assays using a deletion series of pGL4-DKK2
were performed. Co-transfection of the EWS/ETS expression
vector with DKK2 pGL4-DKK2DKpnI or -DKK2DNheI resulted
in a strong induction of the reporter activity (,15-fold) (Fig. 2D–
F), whereas that with pGL4-DKK2DSacI led to only a faint
enhancement (Fig. 2G), indicating that the sequence from -521 to
+49 in the DKK2 gene is not sufficient for EWS/ETS-mediated
enhancement of DKK2 transcription.
To determine whether the EBSs are involved in the EWS/ETS-
induced transactivation of the DKK2 promoter activity, effects of
mutagenesis of EBS-1 and EBS-2 were tested. As shown in Fig. 3A
and 3B, the mutation of EBS-1 suppressed the EWS/ETS-induced
enhancement of the reporter activity of DKK2DKpnI. When both
EBS-1 and EBS-2 were simultaneously mutated, the suppressive
effect against EWS/ETS was further strengthened (Fig. 3B).
Likewise, the mutation of EBS-2 suppressed the EWS/ETS-
induced activation of the reporter activity of DKK2 DNheI-Luc
(Fig. 3A, C).
We next evaluated the direct binding of EWS/ETS proteins to
the EBSs in the DKK2 59 upstream region. In this assay, HEK293
cells were stably transfected with pcDNA-flagDEST and pcDNA-
flagEWS/FLI1, respectively. The overexpression of flag-tagged
EWS/FLI1 protein was confirmed in the IP-western blot assay
(Fig. 4A). DKK2 expression was significantly up-regulated in
HEK-EWS/FLI1 transfectants, approximately 10 fold, compared
with HEK-DEST cells (Fig. 4B). When the ChIP assay was
performed using these cells as illustrated in Fig. 4C (upper figure),
we found that EWS/FLI1 preferentially bound to EBS-2 in HEK-
EWS/FLI1 transfectants (Fig. 4C). Similarly, we also demonstrat-
ed that EWS/FLI1 bound to EBS-2 in SK-ES1 cells (Fig. 4D).
We also examined the effects of EWS/ETS expression on
DKK1 promoter activity. Although we also isolated the 59
upstream region of the DKK1 gene (22108/+80) and conducted
reporter assays as for the DKK2 gene, no significant enhancement
of DKK1 promoter activity mediated by EWS/ETS expression
was observed (data not shown).
Alteration of DKK1 and DKK2 expression by EWS/ETS in
human MPCs
Although the origin of EFT is still unknown, some experimental
results point to hMPCs. In hMPCs, DKK1 has a crucial role in
proliferation and osteogenic differentiation [46,47]. As shown in
Fig. 5A, DKK1, but not DKK2, was expressed in primary hMPCs,
H4-1 cells, UEET-12 cells and UET-13 cells. The expression of
DKK2 protein was also confirmed in EFT whereas not in UET-13
cells (Fig.5B). In EFT cell lines, bycontrast,DKK2,butnot DKK1,
was expressed. We previously reported that the tetracycline-
dependent expression of EWS/ETS confers EFT-like phenotypes
inUET-13cells[35]. Therefore,we testedthe change ofDKK gene
expression using this model. As shown in Fig. 5C–F, both EWS/
FLI1 and EWS/ERG expression resulted in a considerable increase
in DKK2 gene expression. It is worth noting to describe that the
expression level of the DKK1 gene was significantly decreased after
EWS/ETS expression in UET-13 cells.
Mutually exclusive expression of DKK1 and DKK2 in SK-
ES1 cells
To further elucidate the biological roles of DKK genes in EFT
cells, we introduced the DKK1 and DKK2 genes into the EFT cell
line SK-ES1, in which the level of DKK2 expression is relatively
low (Fig. 1A). Independent transfectants were confirmed to indeed
express each gene by RT-PCR and Western blotting (Fig. 6A–C).
Interestingly, when the DKK1 transfectants were examined by
real-time PCR analysis, a reduction in DKK2 expression was
found (Fig. 6D). In contrast, DKK2 overexpression induced a
reduction in DKK1 expression in SK-ES1 cells (Fig. 6E). These
results suggested that the expression of DKK1 and DKK2 related
reciprocally in a mutually exclusive fashion in SK-ES1 cells.
Expression of DKK1 inhibits the formation of
subcutaneous tumors
We next investigated the effect of DKK1 and DKK2 expression
on tumorigenicity by subcutaneously implanting SK-ES1 trans-
fectants into CB17/SCID mice. SK-ES1-DEST#1 and SK-ES1-
DKK1#1 were implanted subcutaneously into CB17/SCID mice.
The mice were sacrificed 28 days after injection. Four of the 10
mice injected with SK-ES1-DEST cells developed tumors
(experiment #1 in Table. 1, Fig. 7A), in the case of SK-ES1-
DKK1#1 cells, however, only one tumor mass was observed after
similar preparation. In addition, the xenograft of DKK1-
expressing SK-ES1 cells was significantly smaller than that of
control SK-ES1-DEST cells (Fig. 7A, B). There were no
morphological and pathological differences between xenografts
formed by SK-ES1-DEST#1 and -DKK1#1 cells. Reproducible
results were obtained by using another independent clone, SK-ES-
DKK1#2 cells (experiment #2 in Table. 1). We also tested the
tumorigenicity of SK-ES1-DKK2 cells in a similar manner.
Table 1. Formation of subcutaneous tumors in CB17/SCID
mice by SK-ES1 cells.
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than control SK-ES1-DEST xenografts, the clone SK-ES1-
DKK2#1 presented no significant difference from SK-ES1-DEST
clones (data not shown).
Discussion
In this study, we found that the expression of DKK2 was
enhanced but that of DKK1 was suppressed in EFT cells. The
suppression of DKK1 expression has been observed in several
tumors [16,48,49,50], and although elevated level of the DKK
family occur in a number of tumor cells, most reports to date have
been concerned with DKK1 and DKK3 [15]. In the case of
DKK2, its suppression in tumors such as malignant melanoma
[17] and gastrointestinal tumors [51] has been reported, but the
elevated levels in cancer have not. Hence, the expression profile of
the DKK family observed here is suggested to be specific to EFT.
We also demonstrated that the expression of DKK2 is regulated
by the direct interaction of the chimeric protein EWS/ETS with
EBS located in the promoter region of the gene. In contrast,
although we also investigated the effect of EWS/ETS on DKK1
transcription, EWS/ETS exhibited no significant effect on DKK1
promoter activity as assessed by the reporter assay. However, the
induction of EWS/ETS expression in human MPCs resulted in
not only an increase in DKK2 gene expression but also a
considerable decrease in DKK1 gene expression. Moreover,
introduction of the DKK2 gene induced a reduction in DKK1
gene expression and vice versa in SK-ES1 cell. Taken together,
our results indicate that EWS/ETS expression in EFT cells
directly induces the up-regulation of DKK2 gene expression that
consequently leads to a suppression of DKK1 expression, although
the further analysis is required for understanding the underlying
mechanism of EWS/ETS-mediated modulation of DKK family
expression.
Although DKK1 is known as a Wnt antagonist, the function of
DKK2 is still controversial. Some studies indicated that DKK2
also acts as an antagonist of Wnt signaling, whereas others showed
that DKK2 behaves rather agonistic to Wnt signaling. In some
tumor types, Wnt antagonists including DKK1 act as tumor
suppressors [19,20,24,52,53]. As we demonstrated in this study,
ectopic expression of DKK1 in EFT cells resulted in the inhibition
of tumor growth in SCID mice, whereas DKK2 expression did not
and even possibly accelerated tumor growth in vivo, demonstrating
that DKK2 does not act as a counterpart of DKK1. Therefore,
our findings support reports that presented DKK2 has a distinct
function from DKK1. As we described above, the up-regulation of
DKK2 consequently leads to a suppression of DKK1 and thus
possibly contributes to EFT phenotype indirectly by interfering
with the suppressive function of DKK1 on tumor growth. To
further investigate the role of DKK2 in EFT formation, we have
tested the effect of temporal DKK2 knockdown by transient
transfection with DKK2 siRNA, whereas no significant influence
on cell growth and cell death was observed as assessed by MTT
assay and Annexin V assay, respectively (data not shown). The
further experiments to elucidate the direct effect of DKK2 on EFT
phenotype are now underway.
Interestingly, it was recently suggested that DKK1 also
functions independently of the canonical Wnt/b–catenin signaling
pathway. For example, several studies have indicated that DKK1-
mediated tumor suppression is independent of canonical Wnt/b–
catenin signaling [20]. It was also reported that Wnt3A-mediated
activation of the canonical Wnt/b–catenin signaling pathway
induces neuritic outgrowth in EFT cells [54], and DKK1 mimics
Wnt activity and induces neuritogenesis in EFT cells. Therefore, it
is possible that DKK2 also has a function independent of Wnt
signaling that is distinct from that of DKK1.
As described above, DKK1 has a significant function in hMPCs
and could stimulate cell proliferation while maintaining the
undifferentiated phenotype [55]. Therefore, adequate DKK
expression is essential for the maintenance of the MPC phenotype.
Although the origins of EFT are still unclear, hMPCs are thought
to be a candidate [56,57] and we previously showed that inducible
EWS/ETS expression in human MPCs confers EFT-like pheno-
types [35]. Since, as we found in this study, EWS/ETS expression
induces the down-regulation of DKK1 expression and up-
regulation of DKK2 in UET-13 cells, an expression profile of
the DKK family typical of EFT cells, it is reasonable to speculate
that EWS/ETS-mediated change in the DKK family expression
profile in hMPCs is involved in the development of EFT.
Consistent with this, interestingly, a recent study revealed that
the expression of DKK1 is up-regulated in EWS/FLI1-silenced
EFT cells [58], in which feature of the mesenchymal progenitor
including the capacity to differentiation into the osteogenic and
adipogenic lineages are conferred. Considering the significance of
DKK1 expression in hMPCs, EWS/ETS-mediated DKK1
suppression could impair the characteristics of hMPCs and
contribute to their transformation into EFT.
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